Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions F Baldini, J Hertel, E Sandt, CC Thinnes, L Neuberger-Castillo, L Pavelka, ... BMC biology 18, 1-21, 2020 | 184 | 2020 |
The Luxembourg Parkinson’s study: a comprehensive approach for stratification and early diagnosis G Hipp, M Vaillant, NJ Diederich, K Roomp, VP Satagopam, P Banda, ... Frontiers in aging neuroscience 10, 326, 2018 | 92 | 2018 |
Prevalence of SARS-CoV-2 infection in the Luxembourgish population–the CON-VINCE study CJ Snoeck, M Vaillant, T Abdelrahman, VP Satagopam, JD Turner, ... MedRxiv, 2020.05. 11.20092916, 2020 | 91 | 2020 |
Genome-wide association and meta-analysis of age at onset in Parkinson disease: evidence from the COURAGE-PD consortium S Grover, AA Kumar Sreelatha, L Pihlstrom, C Domenighetti, C Schulte, ... Neurology 99 (7), e698-e710, 2022 | 36 | 2022 |
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase A van Rumund, L Pavelka, RAJ Esselink, BPM Geurtz, RA Wevers, ... npj Parkinson's Disease 7 (1), 29, 2021 | 19 | 2021 |
Consortium, N.-P.(2020). Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions F Baldini, J Hertel, E Sandt, CC Thinnes, L Neuberger-Castillo, L Pavelka, ... BMC Biol 18 (1), 62, 0 | 12 | |
Polygenic resilience modulates the penetrance of Parkinson disease genetic risk factors H Liu, M Dehestani, C Blauwendraat, MB Makarious, H Leonard, JJ Kim, ... Annals of neurology 92 (2), 270-278, 2022 | 11 | 2022 |
Body-first subtype of Parkinson’s disease with probable REM-sleep behavior disorder is associated with non-motor dominant phenotype L Pavelka, A Rauschenberger, Z Landoulsi, S Pachchek, T Marques, ... Journal of Parkinson's Disease 12 (8), 2561-2573, 2022 | 11 | 2022 |
Age at onset as stratifier in idiopathic Parkinson’s disease–effect of ageing and polygenic risk score on clinical phenotypes L Pavelka, A Rauschenberger, Z Landoulsi, S Pachchek, P May, E Glaab, ... npj Parkinson's Disease 8 (1), 102, 2022 | 10 | 2022 |
Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females CM Capelle, S Ciré, F Hedin, M Hansen, L Pavelka, K Grzyb, D Kyriakis, ... Nature Communications 14 (1), 7461, 2023 | 6 | 2023 |
Retrograde procedural memory in Parkinson’s disease: A cross-sectional, case-control study L Pauly, C Pauly, M Hansen, VE Schröder, A Rauschenberger, AK Leist, ... Journal of Parkinson's Disease 12 (3), 1013-1022, 2022 | 6 | 2022 |
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study S Pachchek, Z Landoulsi, L Pavelka, C Schulte, E Buena-Atienza, ... npj Parkinson's Disease 9 (1), 156, 2023 | 5 | 2023 |
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinsons Dis 7: 29 A van Rumund, L Pavelka, RAJ Esselink, BPM Geurtz, RA Wevers, ... | 5 | 2021 |
Genetic landscape of Parkinson’s disease and related diseases in Luxembourg Z Landoulsi, S Pachchek, DR Bobbili, L Pavelka, P May, R Krüger, ... Frontiers in Aging Neuroscience 15, 1282174, 2023 | 4 | 2023 |
Luxembourg Parkinson’s study-comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism L Pavelka, R Rawal, S Ghosh, C Pauly, L Pauly, AM Hanff, PL Kolber, ... Frontiers in Neurology 14, 1330321, 2023 | 4 | 2023 |
Multilingual Validation of the First French Version of Munich Dysphagia Test—Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study JA Simons, M Vaillant, G Hipp, L Pavelka, L Stute, C Pauly, R Krüger Frontiers in Neurology 10, 1180, 2019 | 4 | 2019 |
Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data S Schmitz, M Vaillant, C Renoux, RL Konsbruck, P Hertz, M Perquin, ... PharmacoEconomics-Open, 1-10, 2022 | 3 | 2022 |
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function PA Barbuti, J Ohnmacht, BFR Santos, PM Antony, F Massart, G Cruciani, ... Scientific Reports 11 (1), 21946, 2021 | 3 | 2021 |
Parkinson’s disease-associated alterations of the gut microbiome can invoke disease-relevant metabolic changes F Baldini, J Hertel, E Sandt, CC Thinnes, L Neuberger-Castillo, L Pavelka, ... bioRxiv, 691030, 2019 | 3 | 2019 |
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE) O Tsurkalenko, D Bulaev, MP O’Sullivan, C Snoeck, S Ghosh, A Kolodkin, ... BMC Infectious Diseases 24 (1), 179, 2024 | 2 | 2024 |